Victor Lobanenkov
Chief
Molecular Pathology Section
NIAID-laboratory of Immunogenetics
Greece
Biography
Dr. Lobanenkov received an M.A. in nuclear physics from the Institute of Physics in 1977 and a Ph.D. in experimental oncology from the Cancer Research Center, Moscow, in 1981. He was molecular carcinogenesis team leader in the All-Union Cancer Center of the former U.S.S.R. and a visiting scholar at the Royal Cancer Hospital, London, until 1990, where he discovered avian CTCF. He was invited to the Fred Hutchinson Cancer Research Center in Seattle as a foreign faculty-in-residence funded by NIH grants.
Research Interest
Three classes of CTCF/BORIS binding in epigenetic regulation Regulation of BORIS and its targets in cellular and viral genomes Translational research of BORIS repressors and of anti-BORIS immune response directed to cancer diagnostics, therapy, and anti-tumor vaccination
